Manulife, Sunlife or Great-West? By the numbers

A matter of eenie, meenie or can we glean an insight into which of these 3 is the best investment by looking at the numbers?

| More on:
The Motley Fool

Canada’s big three life insurance companies are slowly but surely climbing back into investor’s good books.

With equity markets melting up, bond yields lifting and traction being gained on the international strategies of all three, times are relatively good.

Year-to-date, Manulife’s (TSX:MFC,NYSE:MFC) stock has remained true to its high beta roots by leading the group with a 17.5% return.  Great-West’s (TSX:GWO) stock is slightly behind at 16.3% thus far in 2013, and Sunlife (TSX:SLF,NYSE:SLF) brings up the rear at 12.6%.  Relative to the S&P/TSX Composite Index’s flat return, these numbers look pretty good.  Plus, all pay attractive dividends to boot.

The question is, assuming conditions remain favourable, which is the best horse to ride going forward?  Past performance may not be indicative of future returns.

Let’s take a look at some company specific fundamentals as well as the relative value of each to help us properly align our bets.

Profits and growth

Three of the most important metrics to examine when looking at a life insurance, or any financial company for that matter are return on equity (ROE), return on assets (ROA), and growth in book value per share.  The table below provides a summary.

Company Name


10 Yr Avg ROE


10 Yr Avg ROA

5 Yr BVPS Gr







Sun Life












Source:  Capital IQ

Relative to historical profitability metrics, Manulife clearly has the most room left to run.  Although results have improved, the company has seemingly only scratched the surface of returning to past levels.

Same goes for growth.  None of the three have been particularly exceptional at growing book value per share over the past 5 years, however, Manulife was particularly bad.


The great equalizer in investing is of course valuation.  If a company appears poised to rebound, as MFC does, but its shares have already moved to price in this recovery, investors could be left with a poor performing stock.

To help us with this angle, tabled below are the current price/book multiple for each, as well as their 10 year averages.

Company Name


10 Yr Avg P/B

Div Yield









Sun Life




Source:  Capital IQ

Great-West’s dominance of the profitability metrics obviously has carried through to the valuation portion.  It sports a multiple significantly higher than its peers and at just a 12% discount to its long-term average, is the least discounted of the three.

At the other end of the spectrum, even though Sun Life’s profitability has more or less reverted to its long-term averages, its valuation clearly hasn’t.  Sun Life trades at the lowest multiple to book value and sits 36% below its long-term average.  And, it has the highest dividend yield to boot.

If Sun Life’s profitability remains in-line with current levels, it stands to reason that its multiple should move higher.  This could result in a nice move for SLF shareholders over the short to medium-term.

The Foolish Bottom Line

Near sighted moves aside, all three of these companies have a very bright future as a world of opportunity and very favourable demographic trends await.  Execution is always important, but as long as they are able to forego any significant mishaps, it’s tough to see how you’ll lose if you simply buy these companies today and leave them alone for 10 years.

Canadian index funds can be lethal for your portfolio.  If you own or are thinking of purchasing a Canadian index fund, you need to click here to receive our special FREE report “Buy These 5 Companies Instead of Following a Flawed Piece of Advice”.  Your portfolio will thank you for reading this report!

Follow us on Twitter and Facebook for the latest in Foolish investing.

Fool contributor Iain Butler owns shares of Sun Life Financial.  The Motley Fool doesn’t own shares in any of the companies mentioned.   

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

More on Investing

Various Canadian dollars in gray pants pocket
Dividend Stocks

3 Great Dividend Stocks You Can Buy for Less Than $50

Top TSX dividend stocks are now on sale.

Read more »

Target. Stand out from the crowd

Here’s the Next Stock I’m Going to Buy

CN Rail (TSX:CNR) stock looks too cheap going into the October season. I may pick up a few shares.

Read more »

Double exposure of a businessman and stairs - Business Success Concept

3 Stocks You Can Keep Forever

Despite all of the recent volatility, here are three Canadian stocks that you can feel confident loading up on today.

Read more »

tsx today
Stocks for Beginners

TSX Today: What to Watch for in Stocks on Monday, September 25

After tanking by more than 4% last week, the main TSX index now trades with only 2% year-to-date gains.

Read more »

stock analysis
Dividend Stocks

Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime

Are you looking for a stock you can buy and hold for a lifetime? Here are two options to buy…

Read more »

Growing plant shoots on coins

This Growth Stock Could 10X in 10 Years

WELL Health Technologies Inc. (TSX:WELL) is a growth stock in the telehealth space that boasts exciting potential going forward.

Read more »

edit Safety First illustration

3 Safe TSX Stocks to Strengthen Your Portfolio

These three TSX stocks could be excellent defensive bets, given their solid underlying businesses and healthy growth prospects.

Read more »

sale discount best price
Dividend Stocks

These 3 TSX Dividend Stocks Are on Sale Right Now

Here's why undervalued TSX stocks such as Exchange Income are compelling investments for long-term shareholders.

Read more »